Backgrounds/Aims: The aim of this study was to describe clinical and biological changes in a group of patients who underwent pancreaticoduodenectomy (PD) without any complication during the postoperative period. These changes reflect the "natural history" of PD, and a deviation should be considered as a warning sign. Methods: Between January 2000 and December 2009, 131 patients underwent PD. We prospectively collected and retrospectively analyzed demographic data, pathological variables, associated pathological conditions, and preoperative, intraoperative, and postoperative variables. Postoperative variables were validated using an external prospective database of 158 patients. Results: The mean postoperative length of hospital stay was 20.3±4 days. The mean number of days until removal of nasogastric tube was 6.3±1.6 days. The maximal fall in hemoglobin level occurred on day 3 and began to increase after postoperative day (POD) 5, in patients with or without transfusions. The white blood cell count increased on POD 1 and persisted until POD 7. There was a marked rise in aminotransferase levels at POD 3. The peak was significantly higher in patients with hepatic pedicle occlusion (866±236 IU/L versus 146±48 IU/L; p＜0.001). For both γ-glutamyl transpeptidase and alkaline phosphatase, there was a fall on POD1, which persisted until POD 5, followed with a stabilization. Bilirubin decreased progressively from POD 1 onwards. Conclusions: This study facilitates a standardized biological and clinical pathway of follow-up. Patients who do not follow this recovery indicator could be at risk of complications and additional exams should be made to prevent consequences of such complications. 
INTRODUCTION
In 1935, Whipple et al. 1 reported 3 patients with ampullary cancer treated by a 2-stage pancreaticoduodenectomy (PD). During the 1940s, PD became a 1-stage procedure and was performed more frequently. In the 1970s, the average mortality rate was 25% and some authors suggested that it should be discontinued. 2, 3 In the 1990s, PD was performed with a very low mortality rate of ＜4% or with no mortality in some series. 4, 5 A better selection of patients, improvements in the surgical technique and perioperative care contributed to the improved mortality rate. Although the death rate was reduced, rate of associated complications remained at ap-proximately 50%, and that of pancreatic fistulas at 15%.
A complete assessment of clinical and biological changes after PD is required for the early detection of such complications, in order to improve their management.
The aim of this study was to describe clinical and biological changes in a group of patients who underwent PD without any complications during the postoperative period.
The results were controled with an external prospective multicentric database. In this study, the changes reflected the "natural history" of PD, hence, a deviation should be considered a warning sign. Surgical technique and perioperative care PD was performed without pylorus preservation. In all patients, PD was performed with an antrectomy and reconstruction with a serosa to mucosa hand-sewn end-to-side pancreaticogastrostomy, with non-absorbable monofilament sutures, on the posterior wall of the gastric body. In case of small wirsung (＜3 mm) or/and soft pancreas, an external catheter with multiple side holes was inserted into the pancreatic duct. The largest sized stent that could be passed into the pancreatic duct was used. To prevent migration, the stent was secured to the pancreatic parenchyma with two 6-0 absorbable sutures. The stent was brought out through the gastric wall. The stent was externalized through a stab incision in the anterior abdominal wall and connected to a reservoir (urine bag). Gastrojejunostomy and hepaticojejunostomy were performed on the same jejunal loop, which was brought through the transverse mesocolon in a retrocolic position. Lymphadenectomy was routinely performed with skeletonization of the hepatic artery from the hepatic pedicle to the celiac axis, and removal of the retroportal pancreatic lamina on the right aspect of the superior mesenteric artery. 6 No lymphadenectomy was per- cm -Teleflex Medical -France) was placed at the end of the operation. In these patients, enteral feeding was started on postoperative day (POD) 1 after surgery with 500 ml of water. This was progressively increased to 1,000 ml or 1,500 ml of a standardized elemental diet on POD 2 to day 5. Oral diet was initiated 5 to 7 days after the operation if there was no pancreatic fistula or other intra-abdominal complication. (Table 1) . Eleven patients (8.4%) required re-operation. The mortality rate was 5.3%
MATERIALS AND METHODS

Studied internal population
RESULTS
Peoperative and intraoperative results in internal population
(n=7). Causes of death were pulmonary embolism (n=3), hemorrhage (n=2), septic shock (n=1), and biliary peritonitis (n=1). We studied the 43 patients who did not have postoperative complications. The mean findings were summarized in the Blood changes were listed in Table 3 . The maximal fall in hemoglobin level occurred on day 3 and began to increase after POD 5, in patients with or without transfusions (Fig. 3) . The white blood cell count increased on POD 1 and persisted until POD 7. There was a marked rise in aminotransferase levels at POD 3. The peak was significantly higher in patients who had hepatic pedicle occlusion (866±236 IU/L versus 146±48 IU/L; p＜0.001).
Pstoperative results in internal population
For both -glutamyl transpeptidase and alkaline phosphatase, there was a drop on POD 1 (respectively -58.7% and -49.9%), which persisted until day 5 followed by stabilization. Blood hepatic changes in patients with or without preoperative biliary drainage (PBD) were listed in Table 4 . Mean duration between PBD and PD was 14±5 days. Blood changes were listed in Table 5 . The controlled external population confirmed the maximal drop in hemoglobin level on POD 3 (in patients with or without transfusions), the increase in the white blood cell count on POD 1 and during 1 week, and the peak of aminotransferase levels on POD 3. The peak was significantly higher in patients who had hepatic pedicle occlusion (256±126 Units/L versus 76±48 Units/L; p＜0.001). Changes of serological liver function test in patients with or without preoperative biliary drainage were listed in Table 6 . Mean duration between PBD and PD was 15±6 days.
DISCUSSION
Historically, PD is associated with a high rate of mor- 12 (complications that did not require any treatment) were considered. As a result of very strict criteria of inclusion, our studied population was homogeneous.
We aimed to define standard postoperative outcomes in patients after PD for early recognition of complications. 27 Additionally, the complete assessment of the postoperative course can provide better information to the patient.
In the present study, the mean length of stay was about Our data in non-complicated patients indicated that the trend towards the streamlining of perioperative care is a major determiner of length of stay for PD. Selected patients who had signs of complications can enjoy some benefits of fast-track rehabilitation.
The increase in white blood cell count is maximal at 36 In patients with sentinel bleeding or patients at risk of delayed hemorrhage, helical computed tomography scan with 3-dimensional angiography allows for the early diagnosis of pseudo-aneurysms, as shown by our experience.
11,34
The drop in alkaline phosphatase, -glutamyl transferase and bilirubin at POD 1 accounts for biliary decompression.
There was no difference between patients who required PBD and those who did not require PBD. Indeed, the biliary drain allows the drop in bilirubin serum levels from 207 to 135.8 mol/L before PD, but there was no difference between bilirubin serum levels postoperatively. The mean duration between PBD and PD was 14 days, which was potentially too short. The duration of drainage should probably be at least 4 to 6 weeks. Even if the bilirubin level has decreased to normal levels, hepatic function will fully be restored only after at least 4 to 6 weeks. Hepatic mitochondrial functions, 37 depressed cell-mediated immunity, impaired hepatic reticulo-endothelial function, 38 and altered lymphocyte transformation 39 are unlikely to improve within 4 weeks. Bile ductal proliferation and hepatic fibrosis may partially reverse at 4 to 6 weeks after removal of biliary obstruction. 40, 41 There was an increase in transaminase levels after PD.
It could be the consequence of hepatic resection asso- 
